# Eplus Inc: financial statements, quarterly

PLUS · Nasdaq · CIK 1022408 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/plus.md) · [Financials](/companies/plus/financials.md) · [Filings](/companies/plus/filings.md) · [Insiders](/companies/plus/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plus/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [588](/filings/0001140361-24-046230.md) | [509](/filings/0001140361-25-003227.md) | [507 d](/filings/0001140361-26-023171.md) | [536](/filings/0001140361-25-029644.md) | [493](/filings/0001140361-25-040814.md) | [493](/filings/0001140361-26-003725.md) | [478 d](/filings/0001140361-26-023171.md) | [643](/filings/0001140361-26-031274.md) | [609](/filings/0001140361-25-040814.md) | [615](/filings/0001140361-26-003725.md) | [582 d](/filings/0001140361-26-023171.md) | [649](/filings/0001140361-26-031274.md) |
| Cost of revenue | $m | [443](/filings/0001140361-24-046230.md) | [375](/filings/0001140361-25-003227.md) | [416 d](/filings/0001140361-26-023171.md) | [409](/filings/0001140361-25-029644.md) | [366](/filings/0001140361-25-040814.md) | [368](/filings/0001140361-26-003725.md) | [345 d](/filings/0001140361-26-023171.md) | [489](/filings/0001140361-26-031274.md) | [447](/filings/0001140361-25-040814.md) | [456](/filings/0001140361-26-003725.md) | [435 d](/filings/0001140361-26-023171.md) | [498](/filings/0001140361-26-031274.md) |
| Gross profit | $m | [144](/filings/0001140361-24-046230.md) | [134](/filings/0001140361-25-003227.md) | [91.3 d](/filings/0001140361-26-023171.md) | [127](/filings/0001140361-25-029644.md) | [127](/filings/0001140361-25-040814.md) | [125](/filings/0001140361-26-003725.md) | [133 d](/filings/0001140361-26-023171.md) | [154](/filings/0001140361-26-031274.md) | [162](/filings/0001140361-25-040814.md) | [159](/filings/0001140361-26-003725.md) | [147 d](/filings/0001140361-26-023171.md) | [151](/filings/0001140361-26-031274.md) |
| Selling, general and administrative | $m | [92.7](/filings/0001140361-24-046230.md) | [89.4](/filings/0001140361-25-003227.md) | [83.2 d](/filings/0001140361-26-023171.md) | [90.6](/filings/0001140361-25-029644.md) | [94.5](/filings/0001140361-25-040814.md) | [101](/filings/0001140361-26-003725.md) | [101 d](/filings/0001140361-26-023171.md) | [104](/filings/0001140361-26-031274.md) | [106](/filings/0001140361-25-040814.md) | [109](/filings/0001140361-26-003725.md) | [103 d](/filings/0001140361-26-023171.md) | [107](/filings/0001140361-26-031274.md) |
| Operating income | $m | [44.9](/filings/0001140361-24-046230.md) | [38.0](/filings/0001140361-25-003227.md) | [4.6 d](/filings/0001140361-26-023171.md) | [31.5](/filings/0001140361-25-029644.md) | [27.0](/filings/0001140361-25-040814.md) | [16.5](/filings/0001140361-26-003725.md) | [24.8 d](/filings/0001140361-26-023171.md) | [42.9](/filings/0001140361-26-031274.md) | [48.8](/filings/0001140361-25-040814.md) | [43.5](/filings/0001140361-26-003725.md) | [37.6 d](/filings/0001140361-26-023171.md) | [38.8](/filings/0001140361-26-031274.md) |
| Interest expense | $m | [1.2](/filings/0001140361-23-051930.md) | [1.0](/filings/0001140361-24-005910.md) | [0.7 d](/filings/0001140361-24-027200.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [12.3](/filings/0001140361-24-046230.md) | [11.1](/filings/0001140361-25-003227.md) | [1.8 d](/filings/0001140361-26-023171.md) | [9.0](/filings/0001140361-25-029644.md) | [7.5](/filings/0001140361-25-040814.md) | [5.4](/filings/0001140361-26-003725.md) | [7.8 d](/filings/0001140361-26-023171.md) | [11.5](/filings/0001140361-26-031274.md) | [15.8](/filings/0001140361-25-040814.md) | [12.2](/filings/0001140361-26-003725.md) | [11.6 d](/filings/0001140361-26-023171.md) | [11.7](/filings/0001140361-26-031274.md) |
| Net income | $m | [32.7](/filings/0001140361-25-003227.md) | [27.3](/filings/0001140361-25-003227.md) | [24.2 d](/filings/0001140361-26-023171.md) | [27.3](/filings/0001140361-26-003725.md) | [31.3](/filings/0001140361-26-003725.md) | [24.1](/filings/0001140361-26-003725.md) | [21.8 d](/filings/0001140361-26-023171.md) | [42.6](/filings/0001140361-26-031274.md) | [34.9](/filings/0001140361-26-003725.md) | [35.1](/filings/0001140361-26-003725.md) | [25.0 d](/filings/0001140361-26-023171.md) | [30.3](/filings/0001140361-26-031274.md) |
| Diluted EPS | $ per share | [1.22](/filings/0001140361-24-046230.md) | [1.02](/filings/0001140361-25-003227.md) | not reported | [1.02](/filings/0001140361-25-029644.md) | [1.17](/filings/0001140361-25-040814.md) | [0.91](/filings/0001140361-26-003725.md) | not reported | [1.61](/filings/0001140361-26-031274.md) | [1.32](/filings/0001140361-25-040814.md) | [1.33](/filings/0001140361-26-003725.md) | not reported | [1.16](/filings/0001140361-26-031274.md) |
| Basic EPS | $ per share | [1.23](/filings/0001140361-24-046230.md) | [1.02](/filings/0001140361-25-003227.md) | not reported | [1.03](/filings/0001140361-25-029644.md) | [1.18](/filings/0001140361-25-040814.md) | [0.91](/filings/0001140361-26-003725.md) | not reported | [1.62](/filings/0001140361-26-031274.md) | [1.32](/filings/0001140361-25-040814.md) | [1.34](/filings/0001140361-26-003725.md) | not reported | [1.17](/filings/0001140361-26-031274.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [82.5](/filings/0001140361-23-051930.md) | [142](/filings/0001140361-24-005910.md) | [253](/filings/0001140361-25-020204.md) | [350](/filings/0001140361-24-035956.md) | [188](/filings/0001140361-24-046230.md) | [253](/filings/0001140361-25-003227.md) | [389](/filings/0001140361-26-023171.md) | [480](/filings/0001140361-25-029644.md) | [402](/filings/0001140361-25-040814.md) | [326](/filings/0001140361-26-003725.md) | [411](/filings/0001140361-26-031274.md) | [449](/filings/0001140361-26-031274.md) |
| Current assets | $m | [1,269](/filings/0001140361-23-051930.md) | [1,219](/filings/0001140361-24-005910.md) | [1,274](/filings/0001140361-25-020204.md) | [1,264](/filings/0001140361-24-035956.md) | [1,202](/filings/0001140361-24-046230.md) | [1,277](/filings/0001140361-25-003227.md) | [1,358](/filings/0001140361-26-023171.md) | [1,402](/filings/0001140361-25-029644.md) | [1,373](/filings/0001140361-25-040814.md) | [1,454](/filings/0001140361-26-003725.md) | [1,428](/filings/0001140361-26-031274.md) | [1,501](/filings/0001140361-26-031274.md) |
| Total assets | $m | [1,619](/filings/0001140361-23-051930.md) | [1,596](/filings/0001140361-24-005910.md) | [1,653](/filings/0001140361-25-020204.md) | [1,651](/filings/0001140361-24-035956.md) | [1,700](/filings/0001140361-24-046230.md) | [1,766](/filings/0001140361-25-003227.md) | [1,879](/filings/0001140361-26-023171.md) | [1,799](/filings/0001140361-25-029644.md) | [1,767](/filings/0001140361-25-040814.md) | [1,832](/filings/0001140361-26-003725.md) | [1,801](/filings/0001140361-26-031274.md) | [1,867](/filings/0001140361-26-031274.md) |
| Current liabilities | $m | [700](/filings/0001140361-23-051930.md) | [631](/filings/0001140361-24-005910.md) | [657](/filings/0001140361-25-020204.md) | [628](/filings/0001140361-24-035956.md) | [650](/filings/0001140361-24-046230.md) | [697](/filings/0001140361-25-003227.md) | [799](/filings/0001140361-26-023171.md) | [688](/filings/0001140361-25-029644.md) | [628](/filings/0001140361-25-040814.md) | [682](/filings/0001140361-26-003725.md) | [638](/filings/0001140361-26-031274.md) | [704](/filings/0001140361-26-031274.md) |
| Total liabilities | $m | [773](/filings/0001140361-23-051930.md) | [718](/filings/0001140361-24-005910.md) | [752](/filings/0001140361-25-020204.md) | [729](/filings/0001140361-24-035956.md) | [753](/filings/0001140361-24-046230.md) | [803](/filings/0001140361-25-003227.md) | [908](/filings/0001140361-26-023171.md) | [779](/filings/0001140361-25-029644.md) | [721](/filings/0001140361-25-040814.md) | [768](/filings/0001140361-26-003725.md) | [732](/filings/0001140361-26-031274.md) | [795](/filings/0001140361-26-031274.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | [38.8](/filings/0001140361-25-020204.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [846](/filings/0001140361-25-003227.md) | [878](/filings/0001140361-25-003227.md) | [897](/filings/0001140361-26-023171.md) | [922](/filings/0001140361-26-003725.md) | [947](/filings/0001140361-26-003725.md) | [962](/filings/0001140361-26-003725.md) | [971](/filings/0001140361-26-031274.md) | [1,018](/filings/0001140361-26-031274.md) | [1,046](/filings/0001140361-26-003725.md) | [1,063](/filings/0001140361-26-003725.md) | [1,069](/filings/0001140361-26-031274.md) | [1,072](/filings/0001140361-26-031274.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.2 d](/filings/0001140361-24-046230.md) | [133 d](/filings/0001140361-25-003227.md) | [105 d](/filings/0001140361-26-023171.md) | [97.1](/filings/0001140361-25-029644.md) | [(21.6) d](/filings/0001140361-25-040814.md) | [65.7 d](/filings/0001140361-26-003725.md) | [161 d](/filings/0001140361-26-023171.md) | [(99.0)](/filings/0001140361-26-031274.md) | [(34.8) d](/filings/0001140361-25-040814.md) | [(87.4) d](/filings/0001140361-26-003725.md) | [105 d](/filings/0001140361-26-023171.md) | [76.5](/filings/0001140361-26-031274.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.9 d](/filings/0001140361-26-023171.md) | [0.8](/filings/0001140361-26-031274.md) | not reported | not reported | [1.2 d](/filings/0001140361-26-023171.md) | [0.9](/filings/0001140361-26-031274.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001140361-26-003725.md) | [0.0 d](/filings/0001140361-26-023171.md) | [0.0](/filings/0001140361-26-031274.md) | [6.6 d](/filings/0001140361-25-040814.md) | [6.5 d](/filings/0001140361-26-003725.md) | [6.5 d](/filings/0001140361-26-023171.md) | [7.1](/filings/0001140361-26-031274.md) |
| Share repurchases | $m | [0.9 d](/filings/0001140361-24-046230.md) | [1.5 d](/filings/0001140361-25-003227.md) | [0.0 d](/filings/0001140361-26-023171.md) | [11.6](/filings/0001140361-25-029644.md) | [12.0 d](/filings/0001140361-25-040814.md) | [9.9 d](/filings/0001140361-26-003725.md) | [13.5 d](/filings/0001140361-26-023171.md) | [3.3](/filings/0001140361-26-031274.md) | [4.0 d](/filings/0001140361-25-040814.md) | [17.0 d](/filings/0001140361-26-003725.md) | [6.3 d](/filings/0001140361-26-023171.md) | [25.5](/filings/0001140361-26-031274.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.6](/filings/0001140361-23-051930.md) | [26.6](/filings/0001140361-24-005910.md) | [26.6](/filings/0001140361-24-035956.md) | [26.7](/filings/0001140361-24-046230.md) | [26.7](/filings/0001140361-25-003227.md) | [26.8](/filings/0001140361-25-029644.md) | [26.7](/filings/0001140361-25-040814.md) | [26.6](/filings/0001140361-26-003725.md) | [26.4](/filings/0001140361-26-031274.md) | [26.4](/filings/0001140361-25-040814.md) | [26.3](/filings/0001140361-26-003725.md) | [26.1](/filings/0001140361-26-031274.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,090,418 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001140361-26-031274.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.